Aurelius G. Omlin
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Safety and preliminary efficacy results of a new micellar formulation of docetaxel in patients with metastatic castration-resistant prostate cancer - SAKK 67/20 trial.
Journal: Cancer chemotherapy and pharmacology
Published: April 08, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.
Journal: European urology
Published: March 23, 2026
Could we reduce renal toxicity of [177Lu]Lu-PSMA radioligand therapy with furosemide?
Journal: European journal of nuclear medicine and molecular imaging
Published: January 21, 2026
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14).
Journal: European urology oncology
Published: January 18, 2026
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 15, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.
Journal: JCO precision oncology
Published: August 07, 2025
Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer.
Journal: Praxis
Published: May 28, 2025
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis.
Journal: European urology
Published: May 10, 2025
CONTACT-02 and beyond: rethinking immunotherapy strategies in metastatic prostate cancer.
Journal: The Lancet. Oncology
Published: April 22, 2025
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate Cancer.
Journal: European urology oncology
Published: February 12, 2025
Treatment Landscape of Prostate Cancer in the Era of PSMA Radiopharmaceutical Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 04, 2024
Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings.
Journal: Frontiers in oncology
Published: September 04, 2024
Last Updated: 09/26/2026